By: Usman Niazi Seo
Mumbai, October 15, 2025 – Lords Mark Industries Ltd. has officially received registration from the United States Food and Drug Administration (US FDA) for its comprehensive range of surgical consumables, orthopedic supports, and hygiene solutions — a pivotal achievement that showcases its manufacturing prowess and reinforces India’s influence in the global healthcare ecosystem.
The US FDA registration is widely regarded as the benchmark for excellence in product safety, quality, and regulatory compliance. For Indian manufacturers, this recognition is a gateway to regulated global markets, including the US, EU, and the Middle East, paving the way for significant international growth. For Lords Mark Industries, this milestone fuels its trajectory toward becoming a global healthcare leader. It aligns seamlessly with India’s larger goal of emerging as a dominant force in healthcare manufacturing.
The registered product lineup includes an expansive assortment — from essential medical items like Cotton Crepe Bandages, Elastic Adhesive Bandages, Cannula Fixators, and Disinfectant Wet Wipes, to orthopedic and rehabilitation aids such as abdominal belts, lumbar supports, cervical collars, Taylor’s braces, arm slings, cockup splints, and knee immobilizers. The company’s “Lord’s Joy” brand extends its hygiene offering with baby wipes, bed bath wipes, and refreshing wipes.
Cutting-Edge Manufacturing Capabilities
Driving this achievement is Lord’s Mark Industries’ advanced production facility located in Dadra & Nagar Haveli. The site comprises five integrated divisions and is supported by a skilled workforce of more than 100 professionals. The plant is designed to deliver high-precision output, combining efficiency with quality at every step.
Adhering to the 5S methodology for lean manufacturing, the facility integrates a comprehensive Quality Control and Quality Assurance (QC/QA) system, with multiple inspection and validation checkpoints. Key infrastructure includes five loom machines, TFO and cheese winders, dyeing and warping units, 38 stitching machines, and a fully automated elastic adhesive coating system.
This manufacturing unit operates in full compliance with global and national standards — including ISO 13485:2016, WHO-GMP, CDSCO, cGMP, GLP, Indian FDA, and US FDA norms — ensuring consistent delivery of high-performance, safe, and globally competitive products.
Revolutionizing Logistics and Quality Operations
Beyond manufacturing excellence, Lords Mark Industries has reengineered its logistics through real-time digital integration, ensuring seamless delivery across domestic and international markets. Its new predictive logistics model leverages data analytics for route optimization, package traceability, and reduced turnaround times — ultimately enhancing reliability and reducing operational costs.
The company’s robust Six-Step Quality Excellence Framework encompasses all aspects of product development — from precise specification design and stage-wise testing to team training, performance monitoring, corrective action implementation, and continuous refinement. This holistic approach fosters a deep-rooted culture of quality, reflecting the values of ‘Hamesha Aapke Saath’ in daily operations.
Leadership Vision and Global Outlook
Speaking on the company’s aspirations, Mr. Sachidanand Upadhyay, Managing Director of Lords Mark Industries Ltd., shared:
“We are committed to bringing Indian-made healthcare products to the global stage — combining world-class quality with affordability. Receiving FDA registration enhances our capacity to fulfill this commitment and extend our footprint into key international markets.”
Executive Director Mr. Manav Teli, alongside Mr. Niraj Oza, Business Head, has been instrumental in scaling the organization through automation, innovation, and sustainable practices. Commenting on this milestone, Mr. Teli added:
“Securing US FDA registration validates our team’s dedication to superior quality and progressive thinking. By harnessing automation, strict quality controls, and smart logistics, we are crafting a future-ready, transparent, and tech-enabled healthcare supply chain.”
With this achievement, Lords Mark Industries Ltd. — through its subsidiary Lords Mark Global LLC in Texas — joins the elite ranks of Indian healthcare giants recognized by the FDA, including Sun Pharma, Cipla, Dr. Reddy’s, Biocon, Meril Life Sciences, and Poly Medicure. Its presence in the US market marks a strategic move to boost Indian manufacturing capabilities while meeting global demand.
Today, India is home to over 700 US FDA-registered facilities, a testament to its growing leadership in providing safe, high-quality, and affordable healthcare solutions to the world.
